Parexel has introduced its Impact Express clinical trial management system (CTMS) for small to mid-sized biopharmaceutical companies
Parexel said that the use of a single, unified clinical trial management system plays a role in helping biopharmaceutical companies’ plan, track, record, and oversee the complex array of administrative, financial, site-related, and other activities that are critical for the efficient monitoring and management of clinical trials.
Patrick Nadolny, vice president of product management, data and analytics services, Parexel, said: “Parexel developed Impact Express for biopharmaceutical and biotech companies in need of a scalable, rapid-to-deploy and cost-effective CTMS option to intelligently manage the complexities of clinical trials.
“By applying a process-driven approach to trial management and monitoring, biopharma companies will be better able to save time and money while simplifying their drug development journey.”